MeSH tree: D13.444.308
Detecting whether osteosarcoma, a rare but aggressive bone cancer that most often affects children and adolescents, has returned or spread remains a major challenge for patients and doctors. Blood-based biomarkers, which ...
Apr 15, 2026
0
4
Ribosomal RNA (rRNA), made from many copies of ribosomal DNA (rDNA), is the core component that powers ribosomes—protein-building machines in our body. It helps build proteins by linking amino acids together, and can also ...
Some of your most important life partners are the mitochondria that power all your cells. You and these little cellular powerhouses are in a 1.5-billion-year-old evolutionary relationship—but mitochondria brought some baggage. ...
Apr 6, 2026
0
12
Fragments of tumor DNA circulating in the bloodstream of patients with breast cancer can predict whether they are likely to relapse, especially when samples are taken after the patients have received treatments prior to surgery. ...
Mar 26, 2026
0
9
Immunotherapy has been one of the most transformative treatments for cancer patients in recent decades, shifting the emphasis from the broad-spectrum approach of chemotherapy to prompting the immune system's boldest warriors—its ...
For women age 70 and over with a common form of breast cancer, determining "the right size" of treatment can be challenging, in part because clinicians have limited tools to guide individualized treatment decisions. In a ...
Mar 21, 2026
0
17
In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania have shown that a minimally invasive liquid ...
Mar 19, 2026
0
12
A new kind of blood test promises to find cancer early—sometimes even before symptoms appear. The pitch is compelling: a single sample of blood could scan the body for dozens of different cancers at once, catching disease ...
Mar 15, 2026
0
13
Memorial Sloan Kettering Cancer Center investigators and collaborators have tested rezatapopt, an oral p53 reactivator designed for tumors with TP53 Y220C, and observed antitumor activity across multiple solid tumor types ...
Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence within the bladder, according ...
Feb 27, 2026
0
27
